ArticleOncoTargets and therapy2018

Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/β-catenin pathway.

Ze Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.